Skip to main content

Vanguard Canine Parvo Injectable

This page contains information on Vanguard Canine Parvo Injectable for veterinary use.
The information provided typically includes the following:
  • Vanguard Canine Parvo Injectable Indications
  • Warnings and cautions for Vanguard Canine Parvo Injectable
  • Direction and dosage information for Vanguard Canine Parvo Injectable

Vanguard Canine Parvo Injectable

This treatment applies to the following species:
Company: Zoetis

Parvovirus Vaccine

MODIFIED LIVE VIRUS

PARVO

6+ WEEKS

INJECT

FOR EASIER STORAGE & VIEWING

● Pull down on the tab.

● Flip tab out and set bottom tray of vials inside top lid.

This product has been shown to be effective for the vaccination of healthy dogs 6 weeks of age or older against canine parvovirus (CPV) and canine parvovirus type 2c (CPV2c). Duration of immunity has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

The high-titer, low-passage CPV virus in Vanguard Canine Parvo is highly immunogenic and capable of stimulating active immunity in the presence of maternal antibodies. This product does not contain CPV type 2c. Cross protection against CPV type 2c was demonstrated in vaccinated puppies challenged 5 weeks following second vaccination.

Vaccination and revaccination according to label directions have been demonstrated (under field conditions) to result in serum antibody titers that persist for 12-48 months against CPV (Hemagglutination inhibition [HAI] titer ≥ 1:80).

Directions For Use

Shake well. Aseptically administer 1 mL subcutaneously or intramuscularly. Healthy dogs should receive 3 doses, each administered 3 weeks apart. Historically, annual revaccination with this product was recommended. The need for annual booster vaccinations has not been established. For advice on revaccination, consult your veterinarian or the manufacturer.

Precautions

Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Inactivate unused contents before disposal. Contains gentamicin and thimerosal as preservatives. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

VLN 190/PCN 18M1.23

Zoetis Inc., Kalamazoo, MI 49007, USA

25 Vials (1 dose: 1 mL)

40033900

50 Vials (1 dose: 1 mL)

40033908

CPN: 3690160.4

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-359-4414
Customer Service:   888-963-8471
Website:   www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2022-11-29